These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38151291)

  • 1. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
    Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
    Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
    Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
    Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
    J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma.
    Li C; Yuan Q; Xu G; Yang Q; Hou J; Zheng L; Wu G
    World J Surg Oncol; 2022 Apr; 20(1):129. PubMed ID: 35459137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
    Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
    BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma.
    Tang M; Luo W; Zhou Y; Zhang Z; Jiang Z
    Transl Oncol; 2024 Feb; 40():101873. PubMed ID: 38141377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
    Fei H; Han X; Wang Y; Li S
    Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.